✉news BusinessRetail first seen 7 h ago, last 1 h ago, peak #5
Retail biotech favorites SLS, IBRX, VNDA, IOVA vs September slump
Original: Biotech Lagged The Broader Market In September — Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI’s Slump?
Biotech stocks lagged the broader market in September, with the SPDR S&P Biotech ETF (XBI) falling while the wider market held up better. Attention is now on whether retail-favored names SELLAS Life Sciences (SLS), ImmunityBio (IBRX), Vanda Pharmaceuticals (VNDA) and Iovance Biotherapeutics (IOVA) managed to escape the sector's slump. Investors are weighing whether these popular small-cap biotechs diverged from the wider sector weakness.
Why now: Biotech underperformed the broader market last month, prompting retail investors to check whether their favorite small-cap names bucked the trend.
SELLAS Life Sciences (SLS)ImmunityBio (IBRX)Vanda Pharmaceuticals (VNDA)Iovance Biotherapeutics (IOVA)XBI biotech ETF
Rank over time, top of the chart is #1. 3 snapshots from 7 h ago to 1 h ago.
Evidence
- Biotech Lagged The Broader Market In September — Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI’s Slump? · Yahoo Finance
API: https://socialmediatrends-api.osmike.com/v1/trends/448808